Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (511-520 of 596) with videos related to

Pageof 60
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2023
Multiple colorectal adenomas syndrome: The role of MUTYH mutation and the polyps' number in clinical management and colorectal cancer riskSilvia Negro, Quoc Riccardo Bao, Marco Scarpa, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
British Journal of Cancer|June 6, 2022
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?Roberto Moretto, Andrew Elliott, Daniele Rossini, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 7, 2026
Double immunohistochemistry to detect transglutaminase 2-IgA deposits in celiac children: a multicentre studyCarla Giordano, Monica Montuori, Paola Parente, et al.
The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2020
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumabAnnamaria Ruzzo, Francesco Graziano, Irene Bagaloni, et al.
The Oncologist|May 6, 2020
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenFilippo Pietrantonio, Fotios Loupakis, Giovanni Randon, et al.
Pathologica|December 27, 2025
Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experienceFrancesco Pepe, Gianluca Russo, Claudia Scimone, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsRoberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Pageof 60

Showing results (511-520 of 596) with videos related to

Sort By:
Pageof 60
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2023
Multiple colorectal adenomas syndrome: The role of MUTYH mutation and the polyps' number in clinical management and colorectal cancer riskSilvia Negro, Quoc Riccardo Bao, Marco Scarpa, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
British Journal of Cancer|June 6, 2022
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?Roberto Moretto, Andrew Elliott, Daniele Rossini, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 7, 2026
Double immunohistochemistry to detect transglutaminase 2-IgA deposits in celiac children: a multicentre studyCarla Giordano, Monica Montuori, Paola Parente, et al.
The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2020
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumabAnnamaria Ruzzo, Francesco Graziano, Irene Bagaloni, et al.
The Oncologist|May 6, 2020
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenFilippo Pietrantonio, Fotios Loupakis, Giovanni Randon, et al.
Pathologica|December 27, 2025
Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experienceFrancesco Pepe, Gianluca Russo, Claudia Scimone, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsRoberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Pageof 60